ARCHIVES

Chromosomal Abnormalities Predict Long Median Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Tells Cooperative Groups To Submit applications For Extra Multimodality Funds

November 28, 1975

FDA To Expand Disclosure For Advisory Committee Members

April 23, 2010

Firm Buys Rights To NKT Cells From Beth Israel Deaconess.

July 28, 2000

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

July 26, 2013

Analysis Reveals Patient Subset With Lower PFS in Phase III Trial

December 30, 2011

NIH Investigating Cohn Records Leak

August 15, 1986